CD86 and COVID-19: Altogether, our findings of augmented AREG or IL-10 transcription together with low HLA-DR and CD86 surface expression may represent a population of immature monocytes with suppressive properties, mostly augmented in acute COVID-19 patients with more lymphopenia, reduced specific-IFN-γ response and poor prognosis.